Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mentor Brachy Sales May Rise With ASC Code; Firm Seeds Women’s Health

This article was originally published in The Gray Sheet

Executive Summary

Mentor contends that the addition of prostate brachytherapy to the list of ASC covered services, combined with resolution of the firm's supply problems, will boost Q3 sales for the segment

You may also be interested in...



Aventis Gains Expedited Review, March Panel For HIV-Indicated Dermal Filler

Expedited review of Aventis/Dermik Laboratories' Sculptra dermal filler to treat facial lipoatrophy in HIV-positive patients will precede a planned U.S. wrinkle indication, the firm says

Aventis Gains Expedited Review, March Panel For HIV-Indicated Dermal Filler

Expedited review of Aventis/Dermik Laboratories' Sculptra dermal filler to treat facial lipoatrophy in HIV-positive patients will precede a planned U.S. wrinkle indication, the firm says

Breast Implant PMA Timeframes Tested By Inamed “Not-Approvable” Letter

Firms seeking premarket approval for silicone breast implants should conduct tests designed to more closely predict rupture and gel bleed under real-world conditions, according to new FDA draft guidelines

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT019261

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel